- Home
- CMPS vs HLXB Comparison
CMPS vs HLXB Comparison
Compare CMPS & HLXB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- HLXB
- Stock Information
- Founded
- CMPS 2020
- HLXB 2021
- Country
- CMPS United Kingdom
- HLXB United States
- Employees
- CMPS N/A
- HLXB N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- HLXB
- Sector
- CMPS Health Care
- HLXB
- Exchange
- CMPS Nasdaq
- HLXB NYSE
- Market Cap
- CMPS 246.5M
- HLXB 253.2M
- IPO Year
- CMPS 2020
- HLXB 2024
- Fundamental
- Price
- CMPS $3.91
- HLXB $10.85
- Analyst Decision
- CMPS Strong Buy
- HLXB
- Analyst Count
- CMPS 6
- HLXB 0
- Target Price
- CMPS $20.20
- HLXB N/A
- AVG Volume (30 Days)
- CMPS 862.1K
- HLXB 7.6K
- Earning Date
- CMPS 05-08-2025
- HLXB 01-01-0001
- Dividend Yield
- CMPS N/A
- HLXB N/A
- EPS Growth
- CMPS N/A
- HLXB N/A
- EPS
- CMPS N/A
- HLXB 0.36
- Revenue
- CMPS N/A
- HLXB N/A
- Revenue This Year
- CMPS N/A
- HLXB N/A
- Revenue Next Year
- CMPS N/A
- HLXB N/A
- P/E Ratio
- CMPS N/A
- HLXB $30.32
- Revenue Growth
- CMPS N/A
- HLXB N/A
- 52 Week Low
- CMPS $2.49
- HLXB $10.14
- 52 Week High
- CMPS $9.63
- HLXB $11.59
- Technical
- Relative Strength Index (RSI)
- CMPS 58.19
- HLXB N/A
- Support Level
- CMPS $3.62
- HLXB N/A
- Resistance Level
- CMPS $4.00
- HLXB N/A
- Average True Range (ATR)
- CMPS 0.28
- HLXB 0.00
- MACD
- CMPS -0.00
- HLXB 0.00
- Stochastic Oscillator
- CMPS 48.23
- HLXB 0.00
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About HLXB HELIX ACQUISITION CORP. II
Helix Acquisition Corp II is a Blank check company.